KL-50 in post TMZ MMR-deficient GBM

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Craig Horbinski

Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.

Episode metadata supplied by the publisher feed · Published Feb 22, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

KL-50 in post TMZ MMR-deficient GBM

0:00 21:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 21 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on February 22, 2025.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!